Updating how brain tumor records are grouped for national counts
Original title: A WHO CNS5-Aligned Classification Framework for Population-Based Surveillance of Brain and Other Central Nervous System Tumors in the United States
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This is about how tumors are counted and named, not a treatment.
The short version
Experts changed how US brain tumor records are sorted for national counts.
What was studied. A US brain tumor registry worked with doctors who study tumor tissue. Together they matched the registry's tumor groups to the 2021 World Health Organization tumor list.
What they found. They moved 205 codes into new groups and added 2 new codes. The tumor groups hit hardest were the ones called glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary. The change shifted the group or the reporting for 167,038 of 491,804 cases, or 34%.
What this means, and what it doesn't
What it could mean: Reports on how common each brain tumor is may now look different. The names and groups should match what doctors use today more closely. Your own care does not change because of this work.
What it doesn't mean: This is not a new drug, test, or treatment. Nothing here is closer to the clinic than it was before. It is record keeping and counting work. It is not a cure, and it does not promise one.
Source: medRxiv (preprint), October 2, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.